UNUM Therapeutics Funding: $181M Raised, Series B (2015)
UNUM Therapeutics is based in Cambridge, Massachusetts. It has raised $181M in total funding. Latest round: Series B.
UNUM Therapeutics funding overview
UNUM Therapeutics is based in Cambridge, Massachusetts. UNUM Therapeutics has raised $181M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2015. The round record for UNUM Therapeutics runs through 2015; nothing later has been disclosed. Investors on record include Atlas Venture, Brace Pharma, Cowen Private Investments, Jennison Associates, New Leaf Venture Partners, Novo A/S and 3 others. 9 distinct backers are named across the disclosed rounds.
UNUM Therapeutics at a glance
Total raised
$181M
Latest round
Series B
Latest round date
June 2015
Headquarters
Cambridge, Massachusetts
Notable investors
Atlas Venture, Brace Pharma, Cowen Private Investments, Jennison Associates, New Leaf Venture Partners, Novo A/S, Sabby Management, Sectoral Asset Management
Frequently asked about UNUM Therapeutics funding
How much has UNUM Therapeutics raised?
UNUM Therapeutics has raised $181M in total disclosed funding across the rounds on record.
Who has invested in UNUM Therapeutics?
Atlas Venture, Brace Pharma, Cowen Private Investments, Jennison Associates, New Leaf Venture Partners, Novo A/S are named among the investors backing UNUM Therapeutics.
What was the latest UNUM Therapeutics funding round?
The most recent disclosed round is a Series B, announced in June 2015.
Where is UNUM Therapeutics based?
UNUM Therapeutics is based in Cambridge, Massachusetts.
When did UNUM Therapeutics last raise?
The last disclosed UNUM Therapeutics round closed in June 2015 at Series B.
Every UNUM Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
